SS
NMTC icon

SBI Securities’s NeuroOne Medical Technologies NMTC Stock Holding History

SBI Securities’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40 Buy
13
+10
+333% +$41 ﹤0.01% 3721
2026
Q1 		$16 Hold
3
– – ﹤0.01% 3792
2025
Q4 		$15 Hold
3
– – ﹤0.01% 3822
2025
Q3 		$18 Hold
3
– – ﹤0.01% 3933
2025
Q2 		$14 Buy
+3
New +$11 ﹤0.01% 3966

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

SBI Securities's NMTC Position: Q2 2026 in Review

SBI Securities increased its NeuroOne Medical Technologies (NMTC) stake by 333% in Q2 2026, buying an estimated $41 and bringing the position to 13 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

SBI Securities first reported a position in NMTC in Q2 2025 and has held it in 5 quarters since. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • SBI Securities held 13 shares of NeuroOne Medical Technologies worth $40 as of Q2 2026.
  • SBI Securities bought 10 NeuroOne Medical Technologies shares in Q2 2026, an estimated $41.
  • NeuroOne Medical Technologies made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3721 holding.
  • SBI Securities first reported a position in NeuroOne Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.